Diabetes
EMPA1C 10/25
Empagliflozin tablets for effective blood sugar control in type 2 diabetes
Dosage Form
Film-coated Tablets
Packaging
Strip of 10 tablets (10 strips per box)
Composition
Empagliflozin 10 mg / Empagliflozin 25 mg (film-coated tablets)
Product Highlights
- SGLT2 inhibitor for type 2 diabetes management
- Available in 10 mg and 25 mg strengths
- Helps lower blood glucose via urinary glucose excretion
- Film-coated tablets for improved patient compliance
Description
EMPA1C contains Empagliflozin, an SGLT2 (sodium-glucose co-transporter-2) inhibitor used in the management of type 2 diabetes mellitus. It works by reducing glucose reabsorption in the kidneys, promoting excretion of excess glucose through urine, thereby helping lower blood sugar levels. EMPA1C is available in two strengths — 10 mg and 25 mg — to suit individual treatment requirements as advised by a physician. It is typically used alongside diet and exercise as part of a comprehensive diabetes management plan.
